COVID-19: Vaccine Information, Visitor Information and What to Expect

Learn about Seattle Children’s Anti-Racism Organizational Change plan and the independent review to combat systemic racism conducted by the Assessment Committee.

Current Research Studies

Cancer – ALTE1621: Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure: a Phase 2b Randomized Placebo-Controlled Trial

Condition or Therapy:

Cancer

Category:

Cancer and Blood Disorders
Study Number: ALTE1621

What is the goal of this study?

Researchers want to know how well low-dose carvedilol works in preventing heart failure in cancer survivors exposed to high dose anthracyclines.

Who can join the study?

This study may be a good fit for children and young adults who:

are any age,
weigh greater than 40 kg (approx. 88 lbs),
had a cancer diagnosis under the age of 22, and
have completed cancer treatment.

What will happen if my child takes part in this study?

You can read more about this study on clinicaltrials.gov.

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Looking for a Researcher?

Name: First Name Last Name
Area of Focus: Research Center:

©1995–2021 Seattle Children’s Hospital

4800 Sand Point Way NE,

Seattle,

WA

98105

206-987-2000

866-987-2000 (toll-free)

206-987-0391 (TTY)

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.